ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 922

A Potential Role for TLR4 Activation in Osteoarthritis Associated Pain

Rachel E. Miller1, Shingo Ishihara2, Phuong Tran3, Richard J. Miller4 and Anne-Marie Malfait5, 1Rheumatology/Biochemistry, Rush University Medical Center, Chicago, IL, 2Internal Medicine, Rush University Medical Center, Chicago, IL, 3Rheumatology, Rush University Medical Center, Chicago, IL, 4Molecular Biochemistry and Pharmacology, Northwestern University, Chicago, IL, 5Internal Medicine/Biochemistry, Rush University Medical Center, Chicago, IL

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Animal models, chemokines, Osteoarthritis, pain and toll-like receptors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pain: Basic and Clinical Aspects I

Session Type: Abstract Submissions (ACR)

Background/Purpose – Damage associated molecular patterns (DAMPs) result from cellular stress and extracellular matrix breakdown. They may contribute to osteoarthritis (OA) pathogenesis by promoting synovitis and cartilage degradation, via activation of pattern recognition receptors (PRR) on chondrocytes and synovial cells. We hypothesized that DAMPs play a direct role in OA pain through activation of dorsal root ganglia (DRG) neurons. We investigated the effects of three OA-associated DAMPs, S100A8, S100A4, and α2-macroglobulin (α2M) on cultured DRG cells.

Methods – DRG neurons (L3-L5) were isolated from adult C57BL/6 mice (wild type, Tlr4 null or Tlr2 null) and cultured prior to (1) MCP-1 stimulation or (2) Ca2+ mobilization assays. For stimulation assays, cultures were treated overnight with S100A8 (1 μg/mL), S100A4 (1 μg/mL) or α2M (50-100 μg/mL) and supernatants collected for MCP-1 ELISA. The proalgesic chemokine MCP-1 is a key mediator of pain in murine experimental OA. For Ca2+ mobilization assays, cultures were loaded with a Ca2+indicator dye and responses to S100A8 (1 μg/mL) or α2M (50 μg/mL) were recorded. Further, destabilization of the medial meniscus (DMM) or sham surgery was performed in 10-week old male C57BL/6 mice. Mice were euthanized 8 or 16 weeks later and L3-L5 DRG were harvested for culture, with or without the selective TLR4 antagonist, TAK242 (Tocris, 1 μM). After 96 hrs, supernatants were analyzed for MCP-1 levels via ELISA.

Results – Stimulation of DRG cultures with α2M resulted in a concentration-dependent increase of MCP-1 production, where 100μg/ml α2M caused a 10-fold increase compared to unstimulated cells (p<0.0001). These effects are similar to those observed with IL-1. S100A8 was an equally potent inducer of MCP-1 (p<0.0001 compared to control), whereas S100A4 did not stimulate MCP-1 expression.

Responses to α2M or S100A8 were unaltered in DRG cultures of Tlr2 null mice. In contrast, DRG cells from Tlr4 null mice did not produce MCP-1 in response to α2M, whereas the response to S100A8 was 50% suppressed, suggesting that the effects of α2M are mediated through TLR4 whereas S100A8 may use other receptors as well. This was confirmed using a selective TLR4 inhibitor in wild type (wt) DRG cultures.

8 and 16 weeks after DMM, unstimulated DRG cells produced increased amounts of MCP-1 compared to naïve and sham. Addition of TAK242 to the culture medium significantly reduced MCP-1 levels produced by DMM DRG cells, suggesting that TLR4 contributes to MCP-1 production observed after DMM surgery.

Since DRG cultures contain glial cells in addition to sensory neurons, we studied direct effects of α2M and S100A8 on neurons through assessing Ca2+-mobilization responses. On average, 8% of wt DRG neurons responded to S100A8 and 23% responded to α2M, suggesting that DRG neurons can express excitatory receptors for these DAMPs. In Tlr4null DRG, 6% of all neurons responded to S100A8 and none responded to α2M.

Conclusion – These studies suggest a potential role for DAMPs in DRG activation, which may contribute to OA pain. TLR4 plays an important role in these effects but other receptors may also be involved. Our results suggest that PRR may be a novel therapeutic target in OA associated pain.


Disclosure:

R. E. Miller,
None;

S. Ishihara,
None;

P. Tran,
None;

R. J. Miller,
None;

A. M. Malfait,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-potential-role-for-tlr4-activation-in-osteoarthritis-associated-pain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology